ÚLTIMAS NOTÍCIAS

14 Dez 2019Brolucizumab Gets EU Panel Backing for Wet AMD

The treatment, previously approved by the FDA, offers less-frequent injections, and efficacy proven in two head-to-head...

14 Dez 2019FDA Approves New Interoperable Insulin Dosing 'Controller'

The Tandem Diabetes Care Control-IQ Technology is the first to allow communication between interoperable pumps and...

13 Dez 2019FDA Approves Amarin's Vascepa for CV Risk Reduction

The purified, high-dose form of eicosapentaenoic acid was approved for elevated triglycerides as an add-on to high-dose...

13 Dez 2019EXCEL Leaders Answer Back After BBC Exposé

Reaction to claims of study misconduct have dominated the press and social media since the report dropped earlier this...

13 Dez 2019Paclitaxel Pill Tops IV Response, but Needs 9-Hour Fast

Among women with metastatic breast cancer, use of an investigational oral form of paclitaxel yielded a higher overall...

13 Dez 2019'Remarkable' New Data on Menopausal Hormone Therapy

Estrogen alone and estrogen/progestin have opposite effects on breast cancer risk; adding progestin may lead to a...

13 Dez 2019Inpatient Rehabilitation Facility Quality Measure Flawed

Readmission within 30 days failed to distinguish between high- and low-performing inpatient rehabilitation facilities,...

13 Dez 2019Company-Reported, Guideline Author Disclosures Often at Odds

One might expect general agreement between industry-reported numbers and author disclosures of payments, but that...

13 Dez 2019Negative Phase 2 Trial Data Ends Development of PSP Drug

Phase 2 trial results show gosuranemab did not meet primary or key secondary endpoints in patients with progressive...

13 Dez 2019FDA OKs Golodirsen (Vyondys 53) for Duchenne Muscular Dystrophy

Golodirsen is the first treatment for Duchenne muscular dystrophy (DMD) in patients with a confirmed mutation amenable...

13 Dez 2019Jury Still Out on Whether to Treat Subclinical Hypothyroidism in Elderly

A new systematic review suggests elderly patients with overt hypothyroidism should receive levothyroxine treatment, but...

13 Dez 2019Collagen: 'Fountain of Youth' or Edible Hoax?

Used by Chinese women for centuries to maintain youthful appearance, the collagen supplement market in the United...

13 Dez 2019Breakfast Like a King: Three-Meal Diet Improves Type 2 Diabetes

A three-meal diet plan improves glycemic endpoints and leads to weight loss and less insulin use in type 2 diabetes...

13 Dez 2019ImmunoRx in TNBC: Conflicting Results

Two separate studies reach very different endpoints with addition of immunotherapy in triple-negative breast cancer....

12 Dez 2019Senate Confirms Stephen Hahn as New FDA Chief

Dr. Stephen Hahn was on Thursday confirmed as the new head of the U.S. Food and Drug Administration, taking charge at a...

12 Dez 2019Ten-Year Results Support Partial Breast Irradiation

A current phase 3 trial showed that partial breast irradiation ? as opposed to irradiating the whole breast ? could be...

12 Dez 2019Clinicians Can Be That 'One Caring Adult' Who Changes a Life

Parents, teachers, and coaches are often thought of as the people who make a difference in the lives of young people,...

12 Dez 2019Abortion Reversal Study Stopped Early for Severe Bleeding

Several state laws mandate that healthcare providers tell women a medical abortion can be "reversed" using a...

12 Dez 2019Failed ATEMPT: T-DM1 No Safer in Early HER2+ Breast Cancer

Trastuzumab emtansine showed no disease-free survival or safety advantage over paclitaxel + trastuzumab in the adjuvant...

12 Dez 2019Mindfulness for Hypertension Worth Contemplating

Mindfulness training can significantly reduce blood pressure and stress levels in hypertensive patients, early research...

A SUA OPINIÃO

Relativamente à hepatite C, qual a afirmação que lhe parece mais correta:

Indique a sua idade:
1.É uma doença crónica, o tratamento é difícil e a cura é rara.
2.É muito contagiosa e as relações sexuais desprotegidas são o principal fator de risco.
3.É uma doença que tem um tratamento fácil (com comprimidos), rápido (8 a 12 semanas) e muito eficaz.
4.É uma doença que só se desenvolve nos toxicodependentes (consumidores de drogas ilícitas).

CASO CLÍNICO MENSAL

Um novo caso disponível em cada mês. Participe e ganhe!

Consultar e Votar no Caso Mensal
Caso Clínico Dezembro 2019 01 de Dezembro de 2019
Casos Clínico de Novembro de 2019 01 de Novembro de 2019
Casos Clínico de Outubro de 2019 01 de Outubro de 2019
Setembro-Dezembro 2018 11 de Fevereiro de 2019
Janeiro-Março 2019 17 de Abril de 2019
Abril-Junho 2019 28 de Junho de 2019
Julho-Setembro de 2019 30 de Setembro de 2019
Outubro-Dezembro de 2019 31 de Dezembro de 2019
Arte, cultura, tortura? 22 de Outubro de 2019